Out of labs, brain-machine tech in China now hits streets. Though Neuralink grabs headlines worldwide, homegrown firms there quietly push trials forward. Progress hums beneath the radar, steady, without fanfare.
Peng Phoenix runs a pair of startups NeuroXess plus Gestala tackling brain-computer interfaces through implants along with external devices. In places like Sichuan, Hubei, and Zhejiang, regional authorities put health service prices on BCI care so it lines up closer with insurance rules.
What’s pushing things forward? Clear government backing plays a role, while big pools of patients make testing easier. Manufacturing that keeps up with demand matters too. Money flowing in has increased steadily. Firms including BrainCo see bigger checks coming their way.
StairMed Technology stands out among those getting attention. Backers like HongShar Capital place trust in fresh names – Zhiran Medical being one example.
Some recent key deals include Shanghai-based BCI startup Staimed Technology raising $48 million (350 million yuan) in Series B funding in February 2025. BrainCo, a neurotech company developing its noninvasive BCIs and bionic limbs,has also quitely filed for a Hong Kong IPO, according to reports, after raising $287 millionearlier this year.
Chinese startups are now competing with global firms including Synchron and Paradromics.
Right now, brain-computer interfaces mostly help people get back motion, ease discomfort, or handle neurological issues. Yet many specialists think these tools might one day link minds straight to machines, opening paths outside clinics.
Built on solid investment and clear government strategy, China’s brain-computer interface market might expand fast over the next twenty years. Though the tech remains a work in progress, what it could change feels massive by comparison.
